Patent Reform Act of 2007 - Impact on Regenerative Medicine
The author of CELLWISE, one of the newer bio-Blogs out there, asked a question related to the Patent Reform Act of 2007 in a comment on the Pfizer post. He asked:
The article that is cited is right; our patent system is not optimized for today’s innovations or our different industries. The patent office is [...]
Filed under: Big Pharma, Innovation, Intellectual Property, Regenerative Medicine | Tagged: convergent technologies, Innovation, Patent Reform Act, patent thicket, Regenerative Medicine | No Comments »